Exigo Consultores

Exigo Consultores is a Portuguese consultancy specialised in health economics and outcomes research, based in Lisbon. According to its own website, the firm has been developing innovative solutions for the health sector since 2001, positioning itself at the intersection of pharmaceutical market access, epidemiology and evidence synthesis. Its stated identity rests on three pillars — human intelligence, constructive overcoming and objective results — which frame the way it approaches the growing evidentiary demands of health authorities and the pharmaceutical industry. The company organises its work around three main areas of activity. The first, Financing & Market Access for Pharmaceuticals, addresses the fact that access to therapeutic innovation depends on adequate funding from competent authorities whose requirements are increasingly stringent. The second, Epidemiology & Outcomes Research, focuses on real-world evidence generation to better understand diseases, their manifestations in people and the effectiveness of healthcare. The third, Generation & Synthesis of Evidence, responds to the observation that contemporary decision-making in health is heavily influenced by the robustness of available evidence, and that the pharmaceutical industry has a long history of innovation and technological development based on rigorous evidence that is scrutinised throughout a product's life cycle. Exigo therefore operates as a specialist advisory firm serving clients who need to demonstrate value, navigate reimbursement and pricing processes, and build credible clinical and economic dossiers. Its market is primarily Portugal and the wider European health-policy environment, where health technology assessment and real-world evidence requirements have become central to market access. As a private consultancy, Exigo Consultores is not listed on a stock exchange and does not disclose a parent company in the available evidence. Its public presence is centred on its website and a LinkedIn page, through which it communicates its focus on rigour and precision. The firm's longevity — more than two decades of continuous activity in a highly specialised niche — is itself a signal of its established position among Portuguese health-economics consultancies.

Exigo Consultores was established in 2001, according to the company's own website, which states that it has been developing innovative solutions for the health sector since that year. The firm is based in Lisbon, Portugal, as recorded in its Wikidata entry, which describes it simply as a company in Lisbon, Portugal. From its foundation, Exigo has concentrated on the specialised interface between the pharmaceutical industry and health authorities. Its work has developed around the growing evidentiary requirements of payers and regulators: as therapeutic innovation has expanded, so too have the demands placed on manufacturers to demonstrate value, and Exigo positioned itself to support that process. The company's three declared areas of activity — Financing & Market Access for Pharmaceuticals, Epidemiology & Outcomes Research, and Generation & Synthesis of Evidence — reflect the evolution of health-policy priorities over the past two decades, particularly the rise of real-world evidence and health technology assessment as decisive factors in reimbursement and access. Over more than twenty years of operation, Exigo has built a reputation as a specialist consultancy rather than a generalist advisory firm. Its public communications emphasise rigour and precision, human intelligence and constructive overcoming, and a commitment to objective results. The firm maintains a presence on LinkedIn alongside its website, through which it engages with clients and the professional health-economics community. No ownership changes, acquisitions, leadership transitions or listings are documented in the available evidence. Exigo Consultores remains a privately held Portuguese company, active in its original field and market.

• 2001

  Exigo Consultores is founded and begins developing innovative solutions for the health sector.

Specialist health-economics consultancy focused on rigour, precision and objective results for the pharmaceutical and health sector.

• Financing & Market Access for Pharmaceuticals

  Advisory on access to therapeutic innovation, which depends on adequate funding from competent authorities with increasingly stringent requirements.

• Epidemiology & Outcomes Research

  Research oriented to real-world evidence generation to better understand diseases, their manifestations in people and the effectiveness of healthcare.

• Generation & Synthesis of Evidence

  Support for evidence-based decision-making in health, reflecting the pharmaceutical industry's long history of innovation grounded in rigorous evidence scrutinised across the product life cycle.

1. 1Home - Exigoexigoconsultores.com
2. 2Exigo Consultores (Portugal) - Wikidatawikidata.org